Estia Health Care appears to be trading at a 30% discount to what I believe to be a fair value ($2.70)
Estia current share price of $2.06 provides the business with a market cap of ~$530m which is just a tad over the current book value of their buildings including current site under construction. This price also excludes the 4 properties just recently acquired also.
As stated in the annual report PP&E is stated at cost with land valued at just $189m I believe this to be well below the actual value of the land (possibly 50% below real value), however if we assume the land has only increased by 6% provides us with a land value for the current operating site of around $200m or $0.77c/share. If we then add back the carrying amount for the building currently in operation approx. $480m we have land & buildings worth approx. $680m or $2.66/share.
This excludes the operating business altogether which if we add back the non-cash expenses & one off expense of bed amortization charge of $60m & covid related expenses was actually profitable. The business actually produced ~$24m in FCF.
So currently in my eyes the business appears to be very mispriced at ~0.75x real BV.
I also think the business could be bought out for a premium of BV call it 1.5x which equates to a SP of $4 / 94% upside.
Keen to hear any thoughts on this or any arguments as to why it shouldn't trade at atleast real book value given the business is expanding & is profitable.
- Forums
- ASX - By Stock
- 30% upside to fair value?
Estia Health Care appears to be trading at a 30% discount to...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EHE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online